Makoto Tsunozaki Ph.D.

Makoto Tsunozaki Ph.D.

Knobbe Martens

Contact
View Bio
RSS

Latest Posts › Federal Food Drug and Cosmetic Act (FFDCA)

Share:

Novo Nordisk Seeks to Block Compounded Versions of Diabetes / Weight Loss Drug

On October 22, 2024, Novo Nordisk made a submission to the U.S. Food and Drug Administration (FDA) nominating Novo Nordisk’s semaglutide products (WEGOVY, OZEMPIC and RYBELUS) to be included in the FDA’s lists of drug...more

12/17/2024  /  Drug Compounding , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Pharmaceutical Industry , Pharmacies , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide